Market research
002424.SHE Guizhou Bailing Group Pharmaceutical Co., Ltd
SHE CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 6B
- P/E ratio
- Not available
- Analyst target
- 22
- Dividend yield
- Not available
- Beta
- 0.26
Community
Investor discussion
1 comment
Sign in to join the 002424.SHE discussion.
5 years, 5 months ago
Guizhou Bailing Group Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 11.5% below its 200 day moving average.
From a valuation standpoint, the stock is 61.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.7.
Guizhou Bailing Group Pharmaceutical Co., Ltd's total revenue sank by 0.5% to $735M since the same quarter in the previous year.
Its net income has increased by 599.0% to $52M since the same quarter in the previous year.
Finally, its free cash flow fell by 101.9% to $-11M since the same quarter in the previous year.
Based on the above factors, Guizhou Bailing Group Pharmaceutical Co., Ltd gets an overall score of 2/5.